סך נכסים נקיים: renovorx.com (RNXT)

This daily price chart for RenovoRx, Inc. (RNXT) illustrates the price action of an asset with a market capitalization of 0.01. The business relies on exclusive RenovoCath patents, which create a significant barrier to entry for competitors. Clinical trials of the RenovoTAMP platform and the prospect of deals with pharmaceutical behemoths are driving growth. The stability of operations is ensured by the precise transportation of high-tech catheters to medical centers.

This metric reflects the difference between all assets and liabilities, demonstrating the actual value of net assets and the sensitivity of capital to operating expenses. For RenovoRx, Inc. (RNXT), which invests in the RenovoTAMP platform for targeted GI therapy, the equity value dynamics on the balance sheet serve as an indicator of financial stability during clinical trials, allowing for an assessment of the company's margin of safety in the face of market risks.